A Letter Concerning “Aducanumab: What about the Patient?”

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Access to Document

@article{2f2e7cb0aabd4d2cbd186373792bfa71,

title = "A Letter Concerning “Aducanumab: What about the Patient?”",

author = "Sam Gandy",

year = "2022",

month = may,

doi = "10.1002/ana.26333",

language = "English",

volume = "91",

pages = "732--733",

journal = "Annals of Neurology",

issn = "0364-5134",

publisher = "John Wiley & Sons Inc.",

number = "5",

}

TY - JOUR

T1 - A Letter Concerning “Aducanumab

T2 - What about the Patient?”

AU - Gandy, Sam

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85125561759&partnerID=8YFLogxK

U2 - 10.1002/ana.26333

DO - 10.1002/ana.26333

M3 - Letter

C2 - 35178727

AN - SCOPUS:85125561759

SN - 0364-5134

VL - 91

SP - 732

EP - 733

JO - Annals of Neurology

JF - Annals of Neurology

IS - 5

ER -